Researchers at Monash University have discovered an antibiotic that can prevent the life-threatening diarrhea caused by C. difficile. The treatment strategy could also counter diseases caused by other similar bacteria, including anthrax. Studies show that cephamycins can reduce spore production of C. difficile and Bacillus cereus.
Researchers extracted genetic programs for glycopeptide antibiotic production from Actinobacteria, revealing precursors date back over 1 billion years. The study shows that resistance co-evolved with production as a means of self-protection for producing bacteria.
A Finnish study has found that bowel preparation before colon surgery does not reduce surgical site infections or complications. The study of 400 patients showed no benefits to the procedure, suggesting it may be unnecessary.
A team of scientists has discovered previously unknown binding sites on a bacterial enzyme that could guide novel approaches to antibiotic design. The researchers identified key sections of the MraY enzyme that can be targeted with new drugs to inhibit the spread of certain bacterial infections.
Researchers found that cigarette smoke can change the DNA and characteristics of pathogenic microbes like MRSA, making them more resistant to antibiotics. This stress response sparks an emergency mutation, resulting in hardy variants that are better equipped to resist drugs.
Researchers discovered antibiotic properties of a natural product that selectively inhibits pathogen growth while leaving beneficial microbes intact. Synthetic derivatives of this substance have shown enormous antibiotic efficiency against Moraxella catarrhalis and malaria parasites.
Antibiotic-resistant genes were found in London's freshwater sources, with the River Thames having the highest levels. The genes come from human and animal waste, which contaminates water bodies through wastewater discharge. Researchers are now experimenting with slow sand filtration to remove these genes.
Nonprescription antibiotic use is a significant public health concern, with varying prevalence rates across different socioeconomic groups. The study highlights the need for increased awareness and education to prevent unnecessary antibiotic use and its associated adverse events.
Researchers discovered that giving antibiotics to mice and humans before a liver transplant led to improved liver function after surgery. The treatment inhibited bacteria causing inflammation, reducing organ rejection and accelerating cell removal, resulting in better outcomes for patients.
Active surveillance for carbapenem-resistant Enterobacteriaceae (CRE) is now performed in half of centers, a significant increase from the previous study. Financial support for physician stewardship medical directors has also increased to 78% since 2013.
A recent study found that kissing is a significant route of transmission for gonorrhoea, with rates of infection higher among men who kiss their partners compared to those who do not. The researchers argue that increased awareness and control measures are needed to address the rising global incidence of gonorrhoea.
Researchers found that the rate at which a patient's immune system clears slow-growing variants of methicillin-resistant Staphylococcus aureus (MRSA) is crucial in determining whether antibiotics can cure the infection. A new mathematical model suggests that a drug targeting slow-growing MRSA variants may be the most effective treatmen...
A new study found that using a CRP finger-prick blood test reduced antibiotic use by 20% in people with COPD flare-ups without affecting recovery or well-being. This approach may help tackle antibiotic resistance.
A multicenter study found that antibiotic stewardship interventions can significantly reduce overuse of antibiotics for viral acute respiratory infections. By implementing a bundle of evidence-based strategies, institutions can cut antibiotic overuse by one-third, even among high-performing systems.
Researchers at Inserm and Université de Rennes 1 have created new antibiotics effective against Gram-positive and negative multi-resistant bacteria. The compounds, known as peptidomimetics, also appear to prevent the development of resistance when used in mice models.
A new evidence review suggests that few nutritional supplements or dietary interventions offer any protection against cardiovascular disease or death. Some may even cause harm, according to a meta-analysis published in Annals of Internal Medicine.
Researchers successfully combined ceftazidime-avibactam and fosfomycin to fight P. aeruginosa in mouse models, outperforming individual antibiotics. The combination reduced the presence of the bacterium significantly, offering a potential therapeutic strategy against superbugs.
A new study found that nearly two-thirds of pneumonia patients in Michigan hospitals received excessive antibiotic prescriptions, with most written during the discharge process. This over-treatment can lead to physical side effects and does not improve patient outcomes.
A recent study by the University of Birmingham has identified a key pathway involved in protecting bacteria against antibiotics. The researchers discovered that phospholipids are transported towards the outer membrane through a series of proteins, which could lead to the development of new antibiotic treatments.
The study identifies nine master regulators controlling key pathogenic pathways in Pseudomonas aeruginosa, offering potential targets for new antibiotics. An online platform and R package have also been developed to facilitate the analysis of the regulatory network.
Researchers developed a new technique to visualise the distribution of TB drugs in human macrophages at high resolution. The study found that bedaquiline accumulates in lipid droplets inside host cells, forming a reservoir that supplies the drug to Mtb over time.
A recent study found that US hospitals typically wait over a year to prescribe new antibiotics, hindering the market for needed drugs. The delay is attributed to factors such as cost, lack of clear patient guidelines, and inadequate testing for candidate patients.
Researchers have identified a combination of penicillin and clavulanic acid that can overcome resistance in some MRSA strains, making them potentially effective against the superbug. The study suggests that existing medicines could be used to treat one of the world's major strains of MRSA.
Researchers found Cannabidiol effective in killing a wide range of Gram-positive bacteria, including resistant strains, and disrupted biofilms. The compound retained its activity under extended exposure conditions that lead to resistance against other common antibiotics.
A UC Davis study found that educating physicians and patients about safe antibiotic use can reduce overuse by one-third. The study compared two approaches, including educational materials and on-site physician champions, and found significant reductions in inappropriate antibiotic treatment.
A world-first study uses 'good viruses' to eliminate targeted bacteria in green sea turtles without harming non-targeted 'good bacteria'. Researchers have identified the potential for phage therapy as an alternative treatment for bacterial infections in marine animals.
Scientists at Emory Health Sciences have found that combining certain antibiotics can effectively target and defeat bacteria with heteroresistance, a previously underappreciated form of antibiotic resistance. This approach may offer a new strategy for treating resistant infections in hospitalized patients.
Scientists at the University of Warwick have developed a new technology that can detect live bacteria in minutes using bioelectrical signals. This breakthrough could lead to faster diagnosis and treatment of infections, including antibiotic-resistant threats.
A study by Ann & Robert H. Lurie Children's Hospital of Chicago found that nearly 74% of preschool children with community-acquired pneumonia receive unnecessary antibiotics, while 43% undergo chest X-rays despite guidelines against routine use. This overuse contributes to antibiotic resistance and side effects.
Researchers discovered a new class of antibiotics produced by the microbiome that kill bacteria by disrupting their energy metabolism. Fibupeptides, such as lugdunin, have shown promise in treating multidrug-resistant infections, including those caused by MRSA.
Researchers found a compound, C10, that prevented TB bacteria from forming biofilms, making them easier to kill with antibiotics. The compound reversed drug resistance in lab-grown bacteria, potentially shortening treatment regimens for millions suffering from the deadly infection.
A recent US study found that 81% of antibiotics prescribed by dentists to prevent infections prior to dental visits are unnecessary. The study highlights the need for improved antibiotic stewardship in dental practices, particularly in Western US locations.
A recent study published in JAMA Network Open found that antibiotics prescribed by dentists as a preventive measure are unnecessary for 81% of patients. The researchers analyzed nearly 170,000 dentist-written antibiotic prescriptions from 2011 to 2015 and found that only 21% of patients had a cardiac condition that made an antibiotic p...
Researchers at Swansea University have found that Manuka honey is effective in killing antimicrobial resistant bacteria by 39%, improving the activity of some antibiotics. This could provide an alternative treatment for cystic fibrosis patients struggling with deadly, antibiotic-resistant respiratory infections.
A new study has helped develop a treatment option for multi-drug resistant (MDR) infections, including complicated urinary tract infections. The treatment, tebipenem pivoxil hydrobromide, is an oral antibiotic agent that may facilitate earlier discharge from hospital or treat complex infections in the community.
A new study has found that cranberry extract makes bacteria more sensitive to antibiotics, reducing resistance and allowing for lower doses to be effective. This breakthrough could help combat the growing threat of antibiotic resistance.
Lugdunin, a cyclic peptide with strong antimicrobial properties, works by proton transport across bacterial membranes. The researchers discovered that the thiazolidine group in lugdunin forms a critical part of its structure and is essential for its antibacterial activity.
A global study has discovered that concentrations of antibiotics in some world rivers exceed 'safe' levels by up to 300 times. The research team detected antibiotic contamination at 65% of sites monitored across six continents, with the most prevalent being trimethoprim and ciproflaxacin.
Researchers characterized Helicobacter pylori's genetic diversity in individual patients, showing adaptations to specific stomach regions and the impact of antibiotics on its population structure and resistance. The study suggests that antibiotics can select for resistant variants and shape the species' evolutionary dynamics.
Dr. Ana Rita Brochado's research focuses on gram-negative bacteria, which are difficult to treat due to their complex cellular envelope. Her work has shown that certain bacterial strains can be effectively combated using antibiotic combinations and food compounds, like vanillin.
A new modeling study suggests that rapid tests for drug-resistant infections could turn the tables against bacteria, allowing doctors to target resistant strains with precision. However, the researchers found that asymptomatic carriers must also be screened and treated to reverse the spread of resistance.
Researchers have discovered that gamma/delta T cells are the specific cells mediating the mouse's defense against Staphylococcus aureus (MRSA) infection. In a study published in the Proceedings of the National Academy of Sciences, researchers identified V gamma 6/Vdelta 4+ gamma/delta T cells as the key players in this response.
A leading scientist proposes five rules to tackle antibiotic resistance, including protecting new drugs and using diverse antimicrobials. The World Health Organisation warns of a post-antibiotic era, and the study aims to provide a roadmap for integrated microbial management.
A new study found that giving all women a single dose of preventative antibiotics after childbirth involving forceps or vacuum extraction could prevent almost half of maternal infections. The trial, involving 3,420 women, suggests that this simple intervention could reduce antibiotic use by 17% and save the NHS £52.60 per woman.
A recent study from UT Southwestern Medical Center reveals that several species of bacteria can invade the bladder walls in postmenopausal women with urinary tract infections. The findings suggest that antibiotic treatment may not be effective due to high levels of bacterial resistance and a lack of targeted therapies.
Researchers developed a novel machine-learning approach to discover an additional mechanism by which some antibiotics kill bacteria. This secondary mechanism involves activating the bacterial metabolism of nucleotides necessary for DNA replication, leading to increased energy demands and toxic byproducts that contribute to cell death.
Researchers at Cornell University have identified a new stealthy, jumping gene called mcr-9, which resists the world's last-resort antibiotic colistin, threatening global health. The discovery enables early detection and isolation of resistant bacteria in hospitals and food products.
A randomized trial found that adding azithromycin to standard care reduced treatment failure rates by 49% and improved hospital stay durations. Non-smokers showed significant benefits, while current smokers experienced little improvement.
A new drug combination of gentamicin and azithromycin shows promising results in treating treatment-resistant gonorrhoea, with a cure rate of 91% compared to 98% for the current ceftriaxone treatment. The study suggests that gentamicin could be used as an alternative for patients who are allergic or intolerant to ceftriaxone.
Researchers at Thomas Jefferson University have discovered a way to target both of a bacteria's defenses with one hit, weakening its ability to develop antibiotic resistance. By interfering with a specific type of tRNA molecule, the team was able to make bacteria more susceptible to antibiotics.
Fecal transplants could block C. diff's spore from germinating and propagating disease via its toxins, repopulating the gut with diverse microbes. However, current fecal transplant products are not FDA-approved, and patients should refer to clinical trials instead.
Researchers at ETH Zurich develop a new technique, nanoFleming, to rapidly test for antibiotic activity in microorganisms. The method has identified 11 novel peptides with improved efficacy or resistance-bypassing properties.
For long-term acne treatment, doctors are exploring combinations of therapies instead of antibiotics. Benzoyl peroxide and topical retinoids show promise in treating the condition, which affects mainly women in their 20s to 40s.
Women who take antibiotics for two months or more are at increased risk of cardiovascular disease, especially in late adulthood and middle age. The study found that long-duration antibiotic use was associated with an increased risk of heart attack and stroke in women aged 60 or older.
Researchers at the University of Lincoln have successfully reproduced the complex 'anti-tumour antibiotic' kedarcidin, which shows promise in treating cancer and combating drug-resistant bacteria. The breakthrough could lead to new antibiotics and anticancer agents, offering hope for millions facing life-threatening infections.
A new study found that a slow-growing variant form of Lyme bacteria causes severe symptoms and resists standard single-antibiotic treatment. A three-antibiotic cocktail eradicated the infection in mice, offering a potential solution for patients with persistent Lyme disease symptoms.
Researchers developed a dispersion method to effectively kill biofilm bacteria by depleting pyruvate, making resident bacteria susceptible to antibiotics. The method showed improved treatment of infected wounds and enhanced efficacy of conventional antibiotic therapy.
Researchers discovered that bacteria produce a specific stress molecule when exposed to antibiotics, causing them to divide more slowly. This adaptation allows the bacteria to survive while maintaining high tolerance, enabling them to quickly regrow when the antibiotic treatment is ceased.
A KAIST research team created a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in just eight hours. This technology can aid in exploring critical pharmacological patterns of antibiotic interactions and guide clinical therapies.
Researchers developed a drug resistance index to track global trends in antibiotic therapy effectiveness. The study found that high-income countries generally have lower rates of resistance, while low- and middle-income countries face greater challenges due to limited access to newer drugs.